Dm. Runge et al., Epidermal growth factor- and hepatocyte growth factor-receptor activity inserum-free cultures of human hepatocytes, J HEPATOL, 30(2), 1999, pp. 265-274
Background/Aims: Serum-free primary cultures of hepatocytes are a useful to
ol to study factors triggering hepatocyte proliferation and regeneration. W
e have developed a chemically defined serum-free system that allows human h
epatocyte proliferation in the presence of epidermal growth factor and hepa
tocyte growth factor.
Methods: DNA synthesis and accumulation were determined by [H-3]thymidine i
ncorporation and fluorometry, respectively. Western blot analyses and co-im
munoprecipitations were used to investigate the association of proteins inv
olved in epidermal growth factor and hepatocyte growth factor activation an
d signaling: epidermal growth factor receptor, hepatocyte growth factor rec
eptor (MET), urokinase-type plasminogen activator and its receptor, and a m
ember of the signal transducer and activator of transcription family, STAT-
3. Results: Primary human hepatocytes proliferated under serum-free conditi
ons in a chemically defined medium for up to 12 days. Epidermal growth fact
or-receptor and MET were present and functional, decreasing over time. MET,
urokinase-type plasminogen activator and urokinase-type plasminogen activa
tor receptor co-precipitated to varying degrees during the culture period.
STAT-3 co-precipitated with epidermal growth factor-receptor and MET to var
ying degrees.
Conclusions: Proliferation of human hepatocytes can improve by modification
of a chemically defined medium originally used for rat hepatocyte cultures
. In these long-term cultures of human hepatocytes, hepatocyte growth facto
r and epidermal growth factor can stimulate growth and differentiation by i
nteracting with their receptors and initiating downstream signaling. This i
nvolves complex formation of the receptors with other plasma membrane compo
nents for MET (urokinase-type plasminogen activator in context of its recep
tor) and activation of STAT-3 for both receptors.